Immunovant, Inc.

NasdaqGS:IMVT Stock Report

Market Cap: US$4.0b

Immunovant Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:IMVT Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
20 Nov 24SellUS$106,228Eva BarnettIndividual4,174US$25.45
20 Nov 24SellUS$85,334William MaciasIndividual3,353US$25.45
20 Nov 24SellUS$424,811Peter SalzmannIndividual16,692US$25.45
20 Nov 24SellUS$92,893Mark LevineIndividual3,650US$25.45
23 Oct 24SellUS$80,912Jay StoutIndividual2,740US$29.53
23 Oct 24SellUS$94,171Michael GeffnerIndividual3,189US$29.53
23 Oct 24SellUS$128,780Mark LevineIndividual4,361US$29.53
16 Oct 24SellUS$94,172Eva BarnettIndividual3,271US$28.79
16 Oct 24SellUS$91,783William MaciasIndividual3,188US$28.79
16 Oct 24SellUS$82,339Mark LevineIndividual2,860US$28.79
16 Oct 24SellUS$261,845Peter SalzmannIndividual9,095US$28.79
09 Oct 24SellUS$131,838Peter SalzmannIndividual4,460US$29.56
09 Oct 24SellUS$152,589Eva BarnettIndividual5,162US$29.56
21 Aug 24SellUS$480,052Peter SalzmannIndividual15,068US$32.32
21 Aug 24SellUS$120,045Eva BarnettIndividual3,768US$32.32
21 Aug 24SellUS$96,437Julia ButchkoIndividual3,027US$32.32
21 Aug 24SellUS$96,437William MaciasIndividual3,027US$32.32
21 Aug 24SellUS$104,976Mark LevineIndividual3,295US$32.32
24 Jul 24SellUS$111,456Mark LevineIndividual4,015US$27.76
24 Jul 24SellUS$95,939Michael GeffnerIndividual3,456US$27.76
24 Jul 24SellUS$78,089Jay StoutIndividual2,813US$27.76
17 Jul 24SellUS$257,888Peter SalzmannIndividual8,685US$30.55
17 Jul 24SellUS$85,132Julia ButchkoIndividual2,867US$30.55
17 Jul 24SellUS$92,733Eva BarnettIndividual3,123US$30.55
17 Jul 24SellUS$90,386William MaciasIndividual3,044US$30.55
17 Jul 24SellUS$74,382Mark LevineIndividual2,505US$30.55
09 Jul 24SellUS$129,609Peter SalzmannIndividual4,619US$28.06
09 Jul 24SellUS$42,848Julia ButchkoIndividual1,527US$28.06
09 Jul 24SellUS$133,201Eva BarnettIndividual4,747US$28.06
22 May 24SellUS$96,125Mark LevineIndividual3,242US$29.65
22 May 24SellUS$96,274William MaciasIndividual3,247US$29.65
22 May 24SellUS$96,274Julia ButchkoIndividual3,247US$29.65
22 May 24SellUS$479,233Peter SalzmannIndividual16,163US$29.65
22 May 24SellUS$119,845Eva BarnettIndividual4,042US$29.65
24 Apr 24SellUS$114,531Mark LevineIndividual3,963US$28.90
24 Apr 24SellUS$94,243Michael GeffnerIndividual3,261US$28.90
24 Apr 24SellUS$209,207Jay StoutIndividual7,239US$28.90
17 Apr 24SellUS$990,269Peter SalzmannIndividual34,079US$29.94
17 Apr 24SellUS$293,923Julia ButchkoIndividual10,115US$29.94
17 Apr 24SellUS$285,554Mark LevineIndividual9,827US$29.94
17 Apr 24SellUS$356,049Eva BarnettIndividual12,253US$29.94
17 Apr 24SellUS$240,602William MaciasIndividual8,280US$29.94
09 Apr 24SellUS$149,882Peter SalzmannIndividual4,807US$31.18
09 Apr 24SellUS$115,023Eva BarnettIndividual3,689US$31.18
09 Apr 24SellUS$32,833Julia ButchkoIndividual1,053US$31.18
22 Feb 24SellUS$486,362Peter SalzmannIndividual13,454US$36.15
22 Feb 24SellUS$77,144Mark LevineIndividual2,134US$36.15
22 Feb 24SellUS$77,578Julia ButchkoIndividual2,146US$36.15
22 Feb 24SellUS$80,289William MaciasIndividual2,221US$36.15
22 Feb 24SellUS$105,920Eva BarnettIndividual2,930US$36.15
26 Jan 24SellUS$114,778Mark LevineIndividual3,027US$38.45
26 Jan 24SellUS$383,012Michael GeffnerIndividual10,101US$38.45
18 Jan 24SellUS$17,397William MaciasIndividual424US$41.03
11 Jan 24SellUS$147,023Eva BarnettIndividual3,515US$42.43
05 Jan 24SellUS$147,568Peter SalzmannIndividual3,824US$38.59
05 Jan 24SellUS$50,051Julia ButchkoIndividual1,297US$38.59
01 Dec 23SellUS$490,668Atul PandeIndividual12,350US$40.46

Insider Trading Volume

Insider Buying: IMVT insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IMVT?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders1,335,1140.828%
Public Companies79,805,33149.5%
Institutions80,011,26149.6%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 96.95% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
54.4%
Roivant Sciences Ltd.
79,805,331US$2.2b0%no data
8.54%
FMR LLC
12,537,561US$340.5m19.6%0.02%
4.54%
The Vanguard Group, Inc.
6,658,800US$180.9m2.29%no data
3.44%
BlackRock, Inc.
5,053,150US$137.2m2.79%no data
3.09%
T. Rowe Price Group, Inc.
4,540,063US$123.3m52%0.01%
2.96%
Deep Track Capital, LP
4,347,464US$118.1m50.8%3.51%
2.42%
Armistice Capital LLC
3,548,000US$96.4m4.45%2.4%
2.06%
State Street Global Advisors, Inc.
3,022,342US$82.1m11.2%no data
1.62%
Perceptive Advisors LLC
2,378,762US$64.6m23.7%1.38%
1.58%
Viking Global Investors LP
2,320,902US$63.0m0%0.21%
1.28%
Alpine Global Management, LLC
1,882,704US$51.1m-1.31%13.41%
1.03%
Geode Capital Management, LLC
1,510,926US$41.0m6.85%no data
0.96%
Woodline Partners LP
1,414,977US$38.4m-22.4%0.31%
0.93%
Paradigm Biocapital Advisors LP
1,362,827US$37.0m0%1.26%
0.84%
Pictet Asset Management Limited
1,230,309US$33.4m4.72%0.03%
0.83%
Baker Bros. Advisors LP
1,225,410US$33.3m164%0.3%
0.83%
Rock Springs Capital Management LP
1,221,309US$33.2m3.01%1.08%
0.78%
Hood River Capital Management LLC
1,143,567US$31.1m0%0.44%
0.77%
ADAR1 Capital Management, LLC
1,131,707US$30.7m137%5.25%
0.75%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
1,104,910US$30.0m27.7%0.01%
0.75%
Logos Global Management, L.P.
1,100,000US$29.9m91.3%3.44%
0.69%
Franklin Resources, Inc.
1,017,396US$27.6m-1.55%0.01%
0.67%
Capital Research and Management Company
976,237US$26.5m0%no data
0.65%
Principal Global Investors, LLC
951,124US$25.8m69.9%0.01%
0.56%
Tavistock Life Sciences
825,000US$22.4m0%1.4%